COVID-19(16) SARS-CoV-2(10) review(9) COVID‐19(6) coronavirus(5) pharmacokinetics(5) the disease(5) SARS‐CoV‐2(4) Evidence(3) Comprehensive(3) Treatment(3) Tocilizumab(3) acute lung injury(3) Remdesivir(3) acute respiratory syndrome(3) clinical pharmacology(3) HIV(3) Science(3) Antiviral(3) Prophylaxis(3) syndrome(3) therapy(3) US FDA(3) Elimination(2) Gabapentin(2) searched(2) Protease inhibitor(2) active moiety(2) potentially life-threatening(2) Ritonavir(2)